0001209191-14-022917.txt : 20140325 0001209191-14-022917.hdr.sgml : 20140325 20140325140808 ACCESSION NUMBER: 0001209191-14-022917 CONFORMED SUBMISSION TYPE: 4/A PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20140325 FILED AS OF DATE: 20140325 DATE AS OF CHANGE: 20140325 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: NOVAVAX INC CENTRAL INDEX KEY: 0001000694 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 222816046 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 20 FIRSTFIELD ROAD CITY: GAITHERSBURG STATE: MD ZIP: 20878 BUSINESS PHONE: 240-268-2000 MAIL ADDRESS: STREET 1: 20 FIRSTFIELD ROAD CITY: GAITHERSBURG STATE: MD ZIP: 20878 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Erck Stanley C CENTRAL INDEX KEY: 0001342826 FILING VALUES: FORM TYPE: 4/A SEC ACT: 1934 Act SEC FILE NUMBER: 000-26770 FILM NUMBER: 14715519 MAIL ADDRESS: STREET 1: 20 FIRSTFIELD ROAD, #250 CITY: GAITHERSBURG STATE: MD ZIP: 20878 4/A 1 doc4a.xml FORM 4/A SUBMISSION X0306 4/A 2014-03-25 2014-03-25 0 0001000694 NOVAVAX INC NVAX 0001342826 Erck Stanley C C/O NOVAVAX, INC. 20 FIRSTFIELD ROAD GAITHERSBURG MD 20878 1 1 0 0 CEO and President Common Stock 2014-03-25 4 P 0 10000 4.2698 A 84868 D The Reporting Person is amending the Form 4 originally filed to report this purchase solely for the purpose of correcting the column 4 code. The correct code is "A". The reported price is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $4.265 to $4.27, inclusive. The reporting person undertakes to provide to Novavax, Inc., any security holder of Novavax, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each price within the range set forth in this footnote. /s/ John A. Herrmann III, Attorney-in-Fact 2014-03-25